Review
Copyright ©The Author(s) 2021.
World J Stem Cells. Jul 26, 2021; 13(7): 861-876
Published online Jul 26, 2021. doi: 10.4252/wjsc.v13.i7.861
Table 1 Studies using reporter system based on known cancer stem cells biomarkers
Promoter gene/element response
Reporter gene
Tumor type
Functional assays performed for validation
ALDH Far red fluorescent protein (mNeptune)Breast cancer[31]Sphere formation
Limiting-dilution xenotransplantation
Reprogramming of non-CSCs to CSCs after cytotoxic treatments
Extravasation potential
Drug sensitivity in vivo
tdTomato fluorescent proteinBreast and colon cancer[35]Sphere formation
Limiting-dilution xenotransplantation
Drug sensitivity in vivo
DsRed2 fluorescent proteinOral squamous cell carcinoma[29]Sphere formation
Xenotransplantation assays
Drug sensitivity in vitro
CD133Luciferase/RFPGlioma[16]Sphere formation
Transactivation assay
Limiting-dilution xenotransplantation
Drug sensitivity in vivo
Drug sensitivity in vitro
AFP GFPLiver (cholangiocarcinoma) [94]Sphere formationLimiting-dilution
xenotransplantation
Drug sensitivity in vitro
Pancreatic cancer[95] Sphere formation
Limiting-dilution xenotransplantation
Drug sensitivity in vitro
NotchGFPBreast cancer[51] Sphere formation
Limiting-dilution xenotransplantation
Drug sensitivity in vivo
Luminescent proteinLung cancer[52]Sphere formation
Limiting-dilution xenotransplantation
Drug sensitivity in vivo
Drug sensitivity in vitro
TERT GFPOsteosarcoma[53] Sphere formation
Limiting-dilution xenotransplantation
Extravasation potential
Drug sensitivity in vitro
s-SHIP GFPProstate cancer[96] Sphere formation
Limiting-dilution xenotransplantation
Drug sensitivity in vitro
DACH1GFPBreast cancer[97,98]Sphere formation
Xenotransplantation assay
Transactivation assay
LGR5 GFPColorectal cancer[99] Sphere formation
Gene expression profiling of flow-sorted cells